Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16912 | 564 | 30.1 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3349 | 1249 | CARRIER ERYTHROCYTES//VASCULAR IMMUNOTARGETING//NANOERYTHROSOMES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | Author keyword | 26 | 68% | 4% | 23 |
2 | NANOERYTHROSOMES | Author keyword | 18 | 89% | 1% | 8 |
3 | HYPOTONIC DIALYSIS | Author keyword | 15 | 82% | 2% | 9 |
4 | IFEM | Address | 6 | 71% | 1% | 5 |
5 | ERYTHROSOME DERIVATIVES | Author keyword | 6 | 100% | 1% | 4 |
6 | RESEALED ERYTHROCYTES | Author keyword | 4 | 67% | 1% | 4 |
7 | CARRIER ERYTHROCYTE | Author keyword | 4 | 75% | 1% | 3 |
8 | CELLULAR CARRIERS | Author keyword | 3 | 100% | 1% | 3 |
9 | HYPOTONIC PRESWELLING | Author keyword | 3 | 100% | 1% | 3 |
10 | RED BLOOD CELL DERIVATIVES | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | 26 | 68% | 4% | 23 | Search CARRIER+ERYTHROCYTES | Search CARRIER+ERYTHROCYTES |
2 | NANOERYTHROSOMES | 18 | 89% | 1% | 8 | Search NANOERYTHROSOMES | Search NANOERYTHROSOMES |
3 | HYPOTONIC DIALYSIS | 15 | 82% | 2% | 9 | Search HYPOTONIC+DIALYSIS | Search HYPOTONIC+DIALYSIS |
4 | ERYTHROSOME DERIVATIVES | 6 | 100% | 1% | 4 | Search ERYTHROSOME+DERIVATIVES | Search ERYTHROSOME+DERIVATIVES |
5 | RESEALED ERYTHROCYTES | 4 | 67% | 1% | 4 | Search RESEALED+ERYTHROCYTES | Search RESEALED+ERYTHROCYTES |
6 | CARRIER ERYTHROCYTE | 4 | 75% | 1% | 3 | Search CARRIER+ERYTHROCYTE | Search CARRIER+ERYTHROCYTE |
7 | CELLULAR CARRIERS | 3 | 100% | 1% | 3 | Search CELLULAR+CARRIERS | Search CELLULAR+CARRIERS |
8 | HYPOTONIC PRESWELLING | 3 | 100% | 1% | 3 | Search HYPOTONIC+PRESWELLING | Search HYPOTONIC+PRESWELLING |
9 | RED BLOOD CELL DERIVATIVES | 3 | 100% | 1% | 3 | Search RED+BLOOD+CELL+DERIVATIVES | Search RED+BLOOD+CELL+DERIVATIVES |
10 | ITPP | 3 | 60% | 1% | 3 | Search ITPP | Search ITPP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARRIER ERYTHROCYTES | 119 | 84% | 12% | 66 |
2 | LOADED ERYTHROCYTES | 61 | 95% | 4% | 20 |
3 | ENZYME LOADED ERYTHROCYTES | 14 | 100% | 1% | 7 |
4 | PROPHYLACTIC FIBRINOLYSIS | 12 | 58% | 2% | 14 |
5 | DIALYSIS ENCAPSULATION | 11 | 100% | 1% | 6 |
6 | ERYTHROCYTE MEDIATED DELIVERY | 6 | 71% | 1% | 5 |
7 | PHOTOSENSITIZED ERYTHROCYTES | 6 | 100% | 1% | 4 |
8 | AVIDIN ATTACHMENT | 4 | 75% | 1% | 3 |
9 | DEXAMETHASONE 21 PHOSPHATE | 3 | 100% | 1% | 3 |
10 | MOUSE ERYTHROCYTES | 2 | 26% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug delivery by red blood cells: vascular carriers designed by mother nature | 2010 | 63 | 270 | 43% |
Applications of carrier erythrocytes in delivery of biopharmaceuticals | 2007 | 58 | 118 | 65% |
Drug, enzyme and peptide delivery using erythrocytes as carriers | 2004 | 67 | 122 | 80% |
Carrier erythrocytes: An overview | 2003 | 67 | 31 | 84% |
Carrier erythrocytes: recent advances, present status, current trends and future horizons | 2014 | 4 | 78 | 88% |
Cell-based drug delivery | 2008 | 54 | 94 | 38% |
Drug loaded erythrocytes: As novel drug delivery system | 2008 | 15 | 48 | 75% |
Approaches to erythrocyte-mediated drug delivery | 2014 | 3 | 68 | 65% |
Bio-inspired, bioengineered and biomimetic drug delivery carriers | 2011 | 181 | 155 | 11% |
Drug Delivery by Red Blood Cells | 2011 | 11 | 61 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IFEM | 6 | 71% | 0.9% | 5 |
2 | PURINE S | 2 | 67% | 0.4% | 2 |
3 | CHEM BIOL DEF AGCY | 1 | 100% | 0.4% | 2 |
4 | TRANSLAT MED THER EUTPROGRAM TARGETED TH | 1 | 100% | 0.4% | 2 |
5 | BIOL CHEM GIORGIO FORNAINI | 1 | 27% | 0.7% | 4 |
6 | BIOCHEM GIORGIO FORNAINI | 1 | 33% | 0.5% | 3 |
7 | BIOCHEM G FORNAINI | 1 | 18% | 1.1% | 6 |
8 | BORN BUNGE FDN NEUROCHEM | 1 | 50% | 0.2% | 1 |
9 | CNRSUMR 8151INSERMU1022 | 1 | 50% | 0.2% | 1 |
10 | GENDEL LTD | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000111009 | VASCULAR IMMUNOTARGETING//TARGETED THER EUT TRANSLAT NANOMED//TRANSLAT TARGETED THER EUT NANOMED |
2 | 0.0000079780 | SENESCENT CELL ANTIGEN//SENESCENT ERYTHROCYTES//ERYTHROCYTE AGING |
3 | 0.0000069890 | OXYGEN EQUILIBRIUM CURVE//OXYHEMOGLOBIN DISSOCIATION CURVE//ARTERIAL OXYGEN STATUS |
4 | 0.0000063049 | CAROLINA CANC NANOTECHNOL EXCELLENCE//ARTIFICIAL ANTIGEN PRESENTING CELL//SLOAN KETTERING CANC |
5 | 0.0000059636 | FAK NAT BIOCHEM//GLIAL ENRICHED FRACTIONS//NEURONAL ENRICHED FRACTIONS |
6 | 0.0000058578 | MAIDS//LP BM5//LP BM5 MURINE LEUKEMIA VIRUS |
7 | 0.0000057844 | TUMOR GRAFT//MACROTRANSFECTION//MINITRANSFECTION |
8 | 0.0000046573 | RHODANESE//SULFURTRANSFERASE//3 MERCAPTOPYRUVATE |
9 | 0.0000044988 | ERYTHROID GENES//THERMOBIOL//ACLARUBICIN |
10 | 0.0000043381 | STARA ZAGORA MED//THERMOHAEMOLYSIS//PHYS BIOPHYS ROENTGENOL RADIOL |